Ferkolj, I., Ihan, A., Markovic, S., Veceric, Z., & Pohar, M. (2006). Infliximab Reduces the Number of Activated Mucosal Lymphocytes in Patients with Crohn’s Disease. Journal of Gastrointestinal and Liver Diseases, 15(3), 231–235. Retrieved from https://www.jgld.ro/jgld/index.php/jgld/article/view/2006.3.4